EONVANT
EV-DR-2041Decided — review pendingv2

Should Meridian Advisory enter Market A or Market B within the next 12 months?

Owner
Managing Partner
Decided
12 May 2026
Review due
12 November 2026
Preview only — not functional yet

Illustrative scenario — all organizations, figures, sources and evidence shown are fictional sample data

Executive decision summary

v2DecidedReview due 12 November 2026

Sequenced entry — establish in Market A first, prepare Market B for month 9.

Evidence strengthModerate
Confidence range61–74%
Information completenessPartial
Risk exposureElevated
61–74%confidence range

Midpoint 68%

Moderate confidence. The ranging is expressed as a band, not a single figure. The ranking of the two markets is stable across weightings; the timing of the second entry is the sensitive part.

Primary risk

Licensing timelines in Market A are the single largest source of slippage. A three-month delay pushes first revenue past the runway floor and forces a partner reallocation.

Why this recommendation

  • 1Demand for the firm's two strongest practice areas is materially higher in Market A over the 12-month horizon.
  • 2Sequencing keeps cash runway above the partners' stated floor in every modelled case, which simultaneous entry (A + B) does not.
  • 3Market B's advantages are structural and durable, so deferring it costs less than deferring Market A.

What would change this recommendation?

  • Licensing in Market A is confirmed to take longer than 4 months end to end.

    → Market B only

  • An anchor client in Market B commits to a retainer of 12 months or more.

    → Market B only

  • Two senior hires are secured before month 3 rather than after.

    → Simultaneous entry (A + B)

  • Cash runway drops below 9 months for any reason.

    → Defer 6 months

Each condition points to an option that was actually evaluated in this record.

Next recommended action

Commission a written licensing timeline from local counsel in Market A before committing headcount.

02

Assessment

Four independent readouts, counted from the evidence list below. There is no single decision-quality score, because collapsing these into one number hides the thing you need to look at.

Evidence strength

Moderate

3 verified facts, 2 estimates, 1 assumption, 1 prediction, 1 opinion, 1 conflicting item, 1 open unknown — 10 claims in total.

What this means

How much of the reasoning rests on verified sources rather than assumptions, estimates or opinion.

Confidence range

61–74%

Midpoint 68%. Stable ranking, sensitive timing.

What this means

The range within which the recommendation holds. Reported as a range because a single number would imply precision that the evidence does not support.

Information completeness

Partial

1 open unknown and 1 unresolved conflict remain; no primary buyer input.

What this means

Whether the questions this decision depends on have been answered, and which remain open.

Risk exposure

Elevated

One severe-impact risk with moderate likelihood.

What this means

The concentration of severe or unmitigated risks in the chosen option, described in words rather than an invented score.

03

Decision frame

Objective

Add a second revenue geography without reducing delivery quality in the existing market.

Time horizon

12 months, measured from the decision date.

Constraints

  • Maximum 4 additional headcount in the period.
  • Cash runway must not fall below 9 months at any point.
  • No more than one partner relocating.

Out of scope

  • Acquiring an existing local firm.
  • Any market outside the two under review.
  • Changes to the firm's practice-area mix.
04

Options considered

All 5 options that were evaluated, including the ones ruled out. Nothing referenced elsewhere in this record is missing here.

  • Sequenced entry (A then B)

    Recommended

    Establish Market A in months 1–8, begin Market B preparation at month 9.

  • Market A only

    Viable

    Full commitment to Market A, revisit Market B after the horizon.

  • Market B only

    Viable

    Full commitment to Market B, lower friction but slower demand build.

  • Simultaneous entry (A + B)

    Not recommended

    Launch both markets during the same initial operating window.

    High execution risk — not recommended under current constraints. Evaluated in v1 and carried forward so the reason for rejecting it stays on the record.

  • Defer 6 months

    Not recommended

    Hold both, reassess with better licensing and pipeline information.

    Rejected — buys information but forfeits the whole horizon.

05

Criteria and weights

Every weight carries the reason it was set, and the weights total 100%. Weights changed in v2; see what changed below.

Demand for our practice areas

25%

Weighted highest because the firm sells two narrow practices; without demand nothing else matters.

Sequenced entry (A then B)
Strong
Market A only
Strong
Market B only
Moderate
Simultaneous entry (A + B)
Strong
Defer 6 months
Weak

Cost to establish

20%

Directly bounded by the runway constraint the partners set.

Sequenced entry (A then B)
Moderate
Market A only
Moderate
Market B only
Weak
Simultaneous entry (A + B)
Weak
Defer 6 months
Strong

Regulatory and licensing friction

20%

Elevated after v1, because licensing emerged as the dominant timing risk.

Sequenced entry (A then B)
Moderate
Market A only
Weak
Market B only
Strong
Simultaneous entry (A + B)
Weak
Defer 6 months
Moderate

Partner network strength

15%

Referral-led firm; existing relationships shorten time to first mandate.

Sequenced entry (A then B)
Strong
Market A only
Strong
Market B only
Moderate
Simultaneous entry (A + B)
Moderate
Defer 6 months
Moderate

Time to first revenue

12%

Matters, but the firm can absorb one slow quarter.

Sequenced entry (A then B)
Moderate
Market A only
Moderate
Market B only
Weak
Simultaneous entry (A + B)
Strong
Defer 6 months
Weak

Downside if wrong

8%

Lowest weight: both markets can be exited without reputational damage.

Sequenced entry (A then B)
Strong
Market A only
Moderate
Market B only
Moderate
Simultaneous entry (A + B)
Weak
Defer 6 months
Strong

Total weight 100%

06

Evidence

Every claim carries a label, a source and a recency. One pair conflicts and one item is unknown; neither is smoothed over. All sources are fictional.

  • C-01Verified fact

    Market A requires a local licence for advisory work carried out on the ground.

    Fictional regulator licensing guide (sample data) · Updated 2 months ago

  • C-02Verified fact

    Market B allows registration of a foreign advisory entity within 15 business days.

    Fictional national registry documentation (sample data) · Updated 5 weeks ago

  • C-03Estimate

    Establishment cost in Market A is roughly 1.4× the equivalent in Market B.

    Two fictional vendor quotes, averaged · Collected 3 weeks ago

  • C-04Conflicting

    Licensing in Market A completes in about 3 months (local counsel) versus 6–7 months (two peer firms).

    Fictional counsel call; two fictional peer-firm interviews · Both within 6 weeks

  • C-05Assumption

    The firm can hire two mid-level consultants locally within 90 days.

    Stated by the hiring partner, untested · Recorded at framing

  • C-06Prediction

    First mandate in Market A lands in month 6, with a plausible range of months 5 to 8.

    Derived from the firm's last two fictional market entries · Modelled at v2

  • C-07Opinion

    A partner believes Market B carries more long-term brand value for the firm.

    Partner meeting notes · 6 weeks ago

  • C-08Unknown

    Whether the firm's largest existing client would object to work in Market A is unknown.

    Not yet asked · Open question

  • C-09Verified fact

    Current cash runway is 14 months at present burn.

    Internal management accounts (sample data) · Month-end, 3 weeks ago

  • C-10Estimate

    Near-term demand for the firm's two lead practices is materially higher in Market A.

    Three fictional market reports, triangulated · Reports 4–11 months old

07

Risks

Likelihood and impact are stated in words. No invented percentages.

  • R-1

    Licensing in Market A takes twice as long as counsel indicates

    Likelihood
    Moderate
    Impact
    Severe

    Mitigation — Written timeline from counsel before any headcount commitment.

  • R-2

    Local hiring is slower than assumed

    Likelihood
    Moderate
    Impact
    Moderate

    Mitigation — Pre-open one role and shortlist before month 1.

  • R-3

    Delivery quality in the home market degrades during entry

    Likelihood
    Low
    Impact
    Severe

    Mitigation — Freeze partner utilisation on new mandates for two quarters.

  • R-4

    Market B opportunity narrows while deferred

    Likelihood
    Low
    Impact
    Moderate

    Mitigation — Keep two contacts warm with a quarterly check-in.

Challenge engine — independent review

5 findings · independent of the recommendation

The case against this recommendation

Written to argue against the conclusion, not to reassure you about it. Nothing here is softened, shortened, or merged into the recommendation.

The strongest case against this recommendation

Strongest case against

Sequencing optimises for the market with the worst regulatory predictability. If licensing slips, the firm has spent its entire window on the harder market and enters neither properly.

Hidden assumptions

The demand estimate rests on reports up to 11 months old and assumes the firm's practice mix maps onto how those reports segment the market. Neither has been tested with a buyer in Market A.

Downside scenario

Licensing takes 7 months, first mandate slips to month 10, runway reaches the 9-month floor in month 8, and the partners cut the Market B preparation entirely — the sequencing benefit disappears.

Opportunity cost

The same four headcount deployed on the existing market's largest practice would likely produce revenue sooner, with a much narrower confidence range.

Missing evidence that would matter most

No direct buyer conversation in either market. One structured interview with a prospective client in each would move this decision more than any further desk research.

09

Timeline

Decision → Review → Outcome → Learning, on the one spine this product uses for time.

  1. Framedv1

    28 Mar 2026

    Objective, constraints and five options recorded.

  2. Revisedv2

    6 May 2026

    Licensing conflict surfaced; regulatory weight raised from 12% to 20%.

  3. Decided

    12 May 2026

    Sequenced entry chosen at a confidence range of 61–74% (midpoint 68%).

  4. Review due

    12 Nov 2026

    Predicted first mandate in month 6 becomes checkable.

  5. Outcome recorded

    Pending

    Predicted versus actual, decisive criterion, lessons.

10

What changed in v2

v1v2Version history is read-only in this preview

Confidence by version

v1

67–80%

midpoint 74%

v2

61–74%

midpoint 68%

The confidence midpoint fell from 74% in v1 to 68% in v2. Confidence is always carried as a range; the midpoint is only a reading of that range.

What changed

Regulatory and licensing friction moved from 12% to 20% weight, and Market A's score on that criterion fell from Moderate to Weak.

Why

Two peer firms reported licensing timelines roughly twice as long as local counsel indicated. The conflict is unresolved, so the criterion's influence was increased rather than one source being chosen.

Caused by

Claim C-04 — the unresolved licensing conflict

Effect on the recommendation

Simultaneous entry (A + B) dropped out of contention. Sequenced entry remained the recommendation, but the confidence midpoint fell from 74% in v1 to 68% in v2 — the confidence range shifted downward from 67–80% in v1 to 61–74% in v2.
11

Outcome

No outcome recorded yet

The review opens on 12 November 2026. Recording what actually happened is what makes the next decision of this type better.

What the review will contain

  • Predicted versus actual on the two claims that carried the most weight.
  • Which criterion turned out to be decisive, and whether its weight was right.
  • What was over- or under-estimated, stated plainly.
  • Two lessons written in your own words, attached to the record permanently.
  • The resulting change to your calibration on decisions of this type.
← Back to decisions